Grade: Pharmaceutical Grade

Factory Location: Quanzhou

Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa

Sample Provided: no

Payment Terms: L/C

Tamoxifen citrate is a competitive antagonist of estrogen. It is a non-steroidal anti-estrogen drug. It can compete with estrogen (estradiol) in vivo and bind with estrogen in breast cancer cells by Chemicalbook body, thereby inhibiting the effect of estrogen on cancer cells, hindering the growth and development of tumor cells, and exerting anti-cancer effects. It is often used clinically to treat various types of breast cancer, especially in postmenopausal breast cancer women with positive estrogen receptors and progesterone receptors and low levels of prostate-specific antigens.